Chemistry Reference
In-Depth Information
[50] Sun, C.,
et al
., NMR in pharmacokinetic and pharmacodynamic profiling.
Chembiochem
, 2005,
6
, 1592-1600.
[51] Tjernberg, A.,
et al
., Determination of dissociation constants for protein-ligand complexes by
electrospray ionization mass spectrometry.
Anal Chem
, 2004,
76
, 4325-4331.
[52] He, Y.,
et al
., Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by
mass spectrometry.
Bioorg Med Chem Lett
, 2004,
14
, 695-699.
[53] Hofstadler, S. A. and Griffey, R. H., Analysis of noncovalent complexes of DNA and RNA by
mass spectrometry.
Chem Rev
, 2001,
101
, 377-390.
[54] Swayze, E. E.,
et al
., SAR by MS: a ligand based technique for drug lead discovery against
structured RNA targets.
J Med Chem
, 2002,
45
, 3816-3819.
[55] Graffinity. Graffinity's fragment based drug discovery process - RAISE. http://www. graffin-
ity.com/t_elements.php
[56] Huber, W., A new strategy for improved secondary screening and lead optimization using
high-resolution SPR characterization of compound-target interactions.
J Mol Recognit
, 2005,
18
, 273-281.
[57] Karlsson, R.,
et al
., Biosensor analysis of drug-target interactions: direct and competitive
binding assays for investigation of interactions between thrombin and thrombin inhibitors.
Anal Biochem
, 2000,
278
, 1-13.
[58] Maly, D. J.,
et al
., Combinatorial target-guided ligand assembly: identification of potent
subtype-selective c-Src inhibitors.
Proc Natl Acad Sci USA
, 2000,
97
, 2419-2424.
[59] Barker, J., Fragment screening by biochemical assay.
Expert Opin Drug Discov
, 2006,
1
,
225-236.
[60] Blundell, T. L.,
et al
., High-throughput crystallography for lead discovery in drug design.
Nat
Rev Drug Discov
, 2002,
1
, 45-54.
[61] Bemis, G. W. and Murcko, M. A., The properties of known drugs. 1. Molecular frameworks.
J Med Chem
, 1996,
39
, 2887-2893.
[62] Bemis, G. W. and Murcko, M. A., Properties of known drugs. 2. Side chains.
J Med Chem
,
1999,
42
, 5095-5099.
[63] Lepre, C. A., Library design for NMR-based screening.
Drug Discov Today
, 2001,
6
, 133-140.
[64] Aronov, A. M. and Bemis, G. W., A minimalist approach to fragment-based ligand design
using common rings and linkers: application to kinase inhibitors.
Proteins
, 2004,
57
,
36-50.
[65] Baurin, N.,
et al
., Design and characterization of libraries of molecular fragments for use in
NMR screening against protein targets.
J Chem Inf Comput Sci
, 2004,
44
, 2157-2166.
[66] Schuffenhauer, A.,
et al
., Library design for fragment-based screening.
Curr Top Med Chem
,
2005,
5
, 751-762.
[67] Siegal, G.,
et al
., Integration of fragment screening and library design.
Drug Discov Today
,
2007,
12
, 1032-1039.
[68] Babaoglu, K. and Shoichet, B. K., Deconstructing fragment-based inhibitor discovery.
Nat
Chem Biol
, 2006,
2
, 720-723.
[69] Markova, N. DynaPro DLS plate reader for buffer optimization, in
Wyatt Application Note 16
,
2005. http://www.mals.com/literature/appnotes/DynaProAN.cfm
[70] Meyer, B. and Peters, T., NMR spectroscopy techniques for screening and identifying ligand
binding to protein receptors.
Angew Chem Int Ed
, 2003,
42
, 864-890.
[71] Wyss, D. F.,
et al
., NMR-based approaches for lead discovery.
Curr Opin Drug Discov Dev
,
2002,
5
, 630-647.
[72] Mayer, M. and Meyer, B., Characterization of ligand binding by saturation transfer difference
NMR spectroscopy.
Angew Chem Int Ed
, 1999,
38
, 1784-1788.
[73] Dalvit, C.,
et al
., Identification of compoundswith binding affinity to proteins viamagnetization
transfer from bulk water.
J Biomol NMR
, 2000,
18
, 65-68.
